Suppr超能文献

一名年轻患者以多发性神经病作为遗传性转甲状腺素蛋白淀粉样变性(ATTRV)的初始表现:诊断挑战的病例报告

Polyneuropathy as an initial manifestation of Hereditary Transtyretin Amyloidosis (ATTRV) in a young patient: Case report of a diagnostic challenge.

作者信息

Sarmiento Palma Julieth Vivian, Sambracos Parrado Santiago, Echeverria Maria Camila, Ruiz Talero Paula

机构信息

Pontificia Universidad Javeriana, School of Medicine, Bogotá, Colombia.

Department of Internal Medicine, Hospital Universitario San Ignacio, Bogotá, Colombia.

出版信息

Clin Med Insights Case Rep. 2024 May 15;17:11795476241253106. doi: 10.1177/11795476241253106. eCollection 2024.

Abstract

We report the case of a 27-year-old man with transthyretin amyloidosis secondary to the p.Val142Ile mutation with an atypical clinical presentation of predominantly lower limb polyneuropathy without cardiac involvement. p.Val142Ile is mainly associated with cardiopathy, whereas the neuropathic phenotype is mainly associated with p.Val50Met. Our patient belongs to a non-endemic region and due to his lack of support network a possible familial component is unknown. His case represents a diagnostic challenge given the wide heterogeneity of clinical manifestations associated with the disease, with other possible diagnoses of polyneuropathy being reasonably excluded according to prevalence and frequency. The particularly unusual genotype-phenotype association distinguishes this case from the classic description of transthyretin amyloidosis secondary to p.Val142Ile.

摘要

我们报告了一例27岁男性,患有因p.Val142Ile突变导致的转甲状腺素蛋白淀粉样变性,临床表现不典型,主要为下肢多发性神经病,无心脏受累。p.Val142Ile主要与心脏病相关,而神经病变表型主要与p.Val50Met相关。我们的患者来自非流行地区,由于缺乏支持网络,家族性因素未知。鉴于该疾病临床表现的广泛异质性,他的病例具有诊断挑战性,根据患病率和发病率合理排除了其他可能的多发性神经病诊断。这种特别不寻常的基因型-表型关联使该病例有别于继发于p.Val142Ile的转甲状腺素蛋白淀粉样变性的经典描述。

相似文献

1
Polyneuropathy as an initial manifestation of Hereditary Transtyretin Amyloidosis (ATTRV) in a young patient: Case report of a diagnostic challenge.
Clin Med Insights Case Rep. 2024 May 15;17:11795476241253106. doi: 10.1177/11795476241253106. eCollection 2024.
2
Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment.
J Clin Neuromuscul Dis. 2019 Jun;20(4):207-209. doi: 10.1097/CND.0000000000000238.
3
Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina.
Mol Genet Genomic Med. 2021 Nov;9(11):e1812. doi: 10.1002/mgg3.1812. Epub 2021 Oct 20.
5
Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
Neurologia (Engl Ed). 2018 Nov-Dec;33(9):583-589. doi: 10.1016/j.nrl.2016.07.009. Epub 2016 Oct 26.
10
Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Expert Opin Pharmacother. 2023 May-Aug;24(10):1205-1214. doi: 10.1080/14656566.2023.2215925. Epub 2023 May 26.

本文引用的文献

2
Hereditary transthyretin amyloidosis: a case report.
J Med Case Rep. 2022 Jun 25;16(1):248. doi: 10.1186/s13256-022-03437-0.
3
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran.
Pharmgenomics Pers Med. 2022 May 12;15:499-514. doi: 10.2147/PGPM.S359851. eCollection 2022.
4
Prevalence and Outcomes of p.Val142Ile Amyloidosis Cardiomyopathy: A Systematic Review.
Circ Genom Precis Med. 2021 Oct;14(5):e003356. doi: 10.1161/CIRCGEN.121.003356. Epub 2021 Aug 31.
5
The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
J Peripher Nerv Syst. 2021 Jun;26(2):155-159. doi: 10.1111/jns.12451. Epub 2021 May 11.
6
Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care.
Ther Clin Risk Manag. 2020 Feb 21;16:109-123. doi: 10.2147/TCRM.S219979. eCollection 2020.
7
Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy.
Clin Auton Res. 2019 Sep;29(Suppl 1):25-31. doi: 10.1007/s10286-019-00624-w. Epub 2019 Sep 10.
8
Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment.
J Clin Neuromuscul Dis. 2019 Jun;20(4):207-209. doi: 10.1097/CND.0000000000000238.
10
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy.
J Neurol Neurosurg Psychiatry. 2017 May;88(5):457-458. doi: 10.1136/jnnp-2016-315262. Epub 2017 Feb 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验